Association analyses of the polymorphisms of angiotensin-converting enzyme and angiotensinogen genes with diabetic nephropathy in Japanese non-insulin- dependent diabetics

Metabolism: Clinical and Experimental

Volumn 45, Issue 2, 1996, Pages 218-222

  Ohno, Tomio ^a,b   Kawazu, Shoji ^a   Tomono, Shoichi ^a  

^a GUNMA UNIVERSITY   (Japan)

^b GUNMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGED; ANGIOTENSIN BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE PREDISPOSITION; DNA DETERMINATION; FEMALE; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; HUMAN CELL; INTRON; JAPAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEINURIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0029927790     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(96)90057-8     Document Type: Article

References (40)

1. Krowlewski AJ, Warram JH, Rand LI, et al: Epidemiologic approach to the etiology of type 1 diabetes mellitus and its complications. N Engl J Med 317:1390-1398, 1987
2. Viberti GC, Keen H, Wiseman MJ: Raised arterial pressure in parents of proteinuric insulin dependent diabetics. Br Med J 295:515-517, 1987
3. Seaquist ER, Goetz FC, Rich S, et al: Familial clustering of diabetic kidney disease: Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 320:1161-1165, 1989
4. Krolewski AS, Canessa M, Warram JH, et al: Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med 318:140-145, 1988
5. Garr S, Mbanga JC, Thomes T, et al: Increased glomerular filtration rate in patients with IDDM and elevated erythrocyte sodium-lithium countertransport. N Engl J Med 322:500-505, 1990
6. Pettitt DJ, Saad MF, Bennett PM, et al: Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin dependent) diabetes mellitus. Diabetologia 33:438-443, 1990
7. Mangili R, Bending JJ, Scott G, et al: Increased sodium-lithium countertransport activity in red cells of patients with insulin dependent diabetes and nephropathy. N Engl J Med 318:146-150, 1988
8. Walker JD, Tariq T, Viberti GC: Sodium-lithium countertransport activity in red cells of patients with insulin dependent diabetes and nephropathy and their parents. Br Med J 301:635-638, 1990
9. Sealey J, Laragh JH: The renin-angiotensin-aldosterone system for normal regulation of blood pressure and sodium and potassium homeostasis, in Laragh LH, Brenner BM (eds): Hypertension: Pathophysiology, Diagnosis and Management. New York, NY, Raven, 1990, pp 1287-1318
10. Morise T, Yoshiro T, Takeda R: Angiotensin-converting enzyme polymorphism and essential hypertension. Lancet 343:125, 1994 (letter)
11. Hata A, Namikawa C, Sasaki M, et al: Angiotensinogen as a risk factor for essential hypertension in Japan. J Clin Invest 93:1285-1287, 1994
12. Marre M, Bernadet P, Gallois Y, et al: Relationships between angiotensin I converting enzyme gene polymorphism, plasma level, and diabetic retinal and renal complications. Diabetes 43:384-388, 1994
13. Doria A, Warram JH, Krolewski AS: Genetic predisposition to diabetic nephropathy. Evidence for a role of angiotensin I-converting enzyme gene. Diabetes 43:690-695, 1994
14. Cambien F, Poirier O, Lecerf L, et al: Deletion polymorphism in the gene for angiotensin converting enzyme is a potent risk factor for myocardial infarction. Nature 359:641-644, 1994
15. Zhao Y, Higashimori K, Higaki J, et al: Significance of the deletion polymorphism of the angiotensin converting enzyme gene as a risk factor for myocardial infarction in Japanese. Hypertens Res 17:55-57, 1993
16. Ohishi M, Fujii K, Minamino T, et al: A potent genetic risk factor for restenosis. Nature 5:324-325, 1993
17. Marian A, Yu Q, Workman R, et al: Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet 342:1085-1086, 1993
18. World Health Organization: Diabetes mellitus. WHO Tech Rep Ser 727:1-113, 1985
19. Kasahara Y, Ashihara Y: Colorimetry of angiotensin-I converting enzyme activity in serum. Clin Chem 27:1922-1925, 1981
20. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual (ed 2). Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1989
21. Zee RYL, Lou Y-K, Griffiths LR, et al: Association of a polymorphism of the angiotensin I-converting enzyme gene with essential hypertension. Biochem Biophys Res Commun 184:9-15, 1992
22. Gaulfield M, Lavender P, Farrall M, et al: Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med 330:1629-1633, 1994
23. Jeunemaitre X, Soubier F, Kotelevtsev Y, et al: Molecular basis of human hypertension: Role of angiotensinogen. Cell 71:169-180, 1992
24. Parving H-H, Gall MA, Skott P, et al: Prevalence and causes of albuminuria in non-insulin-dependent diabetic (NIDDM) patients. Diabetologia 33:48A, 1990 (abstr)
25. Caldwell PRB, Seegal BC, Hsu KC, et al: Angiotensin-converting enzyme: Vascular endothelial localization. Science 191:1050-1051, 1976
26. Williams TA, Hooper NM, Turner AJ: Characterization of neural and endothelial forms of angiotensin converting enzyme in pig brain. J Neurochem 57:193-199, 1991
27. Defendini R, Zimmerman EA, Weare JA, et al: Angiotensin-converting enzyme in epithelial and neuroepithelial cells. Neuroendocrinology 37:32-40, 1983
28. Tiret L, Rigat B, Visvikis S, et al: Evidence from combined segregation and linkage analysis, that a variant of the angiotensinogen 1 converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 51:197-205, 1992
29. Rigat B, Hubert C, Alhenc-Gelas F, et al: An insertion/ deletion polymorphism in the angiotensin 1 converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343-1346, 1990
30. Costerousse O, Allegrini J, Lopez M, et al: Angiotensin 1-converting enzyme in human circulating mononuclear cells: Genetic polymorphism of expression in T-lymphocytes. Biochem J 290:33-40, 1993
31. Hsueh WA: Effect of renin-angiotensin system in the vascular disease of type II diabetes. Am J Med 92:13S-19S, 1992
32. Vismanathan M, Stromberg C, Seltzer A, et al: Balloon angioplasty enhances the expression of angiotensin II ATI receptors in neointima of rat aorta. J Clin Invest 90:1707-1712, 1992
33. Graham A, Macgregor MA: Blood pressure, angiotensin-converting enzyme (ACE) inhibitors, and the kidney. Am J Med 92:20S-27S, 1992 (suppl 4B)
34. Homma T, Hoover RL, Ichikawa I, et al: Angiotensin II induces hypertrophy and stimulates collagen production in cultured rat glomerular mesangial cell. Clin Res 38:358, 1990
35. Ridker PM, Gabouly CL, Conlin PR, et al: Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Circulation 87:1969-1973, 1993
36. Tilet L, Kee F, Poirier O, et al: Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction. Lancet 341:991-992, 1993
37. Raynolds MV, Bristow MR, Bush EW, et al: Angiotensin-converting enzyme DD genotype in patients with ischemic or idiopathic dilated cardiomyopathy. Lancet 30:1073-1075, 1993
38. Jarrett RJ, Viberti GC, Argyropoulos A, et al: Microalbuminuria predicts mortality in non-insulin-dependent diabetes. Diabetic Med 1:17-20, 1984
39. Mogensen CE: Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 310:356-360, 1984
40. Decker T, Feldt-Rasmussen B, Borch-Johnsen K, et al: Albuminuria reflects widespread vascular damage: The Steno hypothesis. Diabetologia 32:219-226, 1989